In vivo experiments showed that DEL-1 administration increased the expression of SIRT1 and SERCA2, thereby ameliorating insulin resistance in skeletal muscle of high fat diet (HFD)-fed mice and improving HFD-impaired glucose tolerance and insulin sensitivity (43). The gene discussed is SIRT1; the disease is Insulin resistance.